|
1
|
Ito K and Adcock IM: Histone acetylation
and histone deacetylation. Mol Biotechnol. 20:99–106. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Glass CK and Rosenfeld MG: The coregulator
exchange in transcriptional functions of nuclear receptors. Genes
Dev. 14:121–141. 2000.PubMed/NCBI
|
|
3
|
Ropero S and Esteller M: The role of
histone deacetylases (HDACs) in human cancer. Mol Oncol. 1:19–25.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang XJ and Seto E: The Rpd3/Hda1 family
of lysine deacetylases: From bacteria and yeast to mice and men.
Nat Rev Mol Cell Biol. 9:206–218. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Johnstone RW: Histone-deacetylase
inhibitors: Novel drugs for the treatment of cancer. Nat Rev Drug
Discov. 1:287–299. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lagger G, O'Carroll D, Rembold M, Khier H,
Tischler J, Weitzer G, Schuettengruber B, Hauser C, Brunmeir R,
Jenuwein T, et al: Essential function of histone deacetylase 1 in
proliferation control and CDK inhibitor repression. EMBO J.
21:2672–2681. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Harms KL and Chen X: Histone deacetylase 2
modulates p53 transcriptional activities through regulation of
p53-DNA binding activity. Cancer Res. 67:3145–3152. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lei WW, Zhang KH, Pan XC, Wang DM, Hu Y,
Yang YN and Song JG: Histone deacetylase 1 and 2 differentially
regulate apoptosis by opposing effects on extracellular
signal-regulated kinase 1/2. Cell Death Dis. 1:e442010. View Article : Google Scholar
|
|
9
|
Weichert W: HDAC expression and clinical
prognosis in human malignancies. Cancer Lett. 280:168–176. 2009.
View Article : Google Scholar
|
|
10
|
Ramsey MR, He L, Forster N, Ory B and
Ellisen LW: Physical association of HDAC1 and HDAC2 with p63
mediates transcriptional repression and tumor maintenance in
squamous cell carcinoma. Cancer Res. 71:4373–4379. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Buurman R, Gürlevik E, Schäffer V, Eilers
M, Sandbothe M, Kreipe H, Wilkens L, Schlegelberger B, Kühnel F and
Skawran B: Histone deacetylases activate hepatocyte growth factor
signaling by repressing microRNA-449 in hepatocellular carcinoma
cells. Gastroenterology. 143:811–820. e1–e15. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fritzsche FR, Weichert W, Röske A, Gekeler
V, Beckers T, Stephan C, Jung K, Scholman K, Denkert C, Dietel M,
et al: Class I histone deacetylases 1, 2 and 3 are highly expressed
in renal cell cancer. BMC Cancer. 8:3812008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Weichert W, Röske A, Gekeler V, Beckers T,
Stephan C, Jung K, Fritzsche FR, Niesporek S, Denkert C, Dietel M,
et al: Histone deacetylases 1, 2 and 3 are highly expressed in
prostate cancer and HDAC2 expression is associated with shorter PSA
relapse time after radical prostatectomy. Br J Cancer. 98:604–610.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Weichert W, Röske A, Niesporek S, Noske A,
Buckendahl AC, Dietel M, Gekeler V, Boehm M, Beckers T and Denkert
C: Class I histone deacetylase expression has independent
prognostic impact in human colorectal cancer: Specific role of
class I histone deacetylases in vitro and in vivo. Clin Cancer Res.
14:1669–1677. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lau WY: The history of liver surgery. J R
Coll Surg Edinb. 42:303–309. 1997.PubMed/NCBI
|
|
18
|
Llovet JM, Ricci S, Mazzaferro V, Hilgard
P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A,
et al: SHARP Investigators Study Group: Sorafenib in advanced
hepatocellular carcinoma. N Engl J Med. 359:378–390. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Portolani N, Coniglio A, Ghidoni S,
Giovanelli M, Benetti A, Tiberio GA and Giulini SM: Early and late
recurrence after liver resection for hepatocellular carcinoma:
Prognostic and therapeutic implications. Ann Surg. 243:229–235.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rahbari NN, Koch M, Schmidt T, Motschall
E, Bruckner T, Weidmann K, Mehrabi A, Büchler MW and Weitz J: Meta-
analysis of the clamp-crushing technique for transection of the
parenchyma in elective hepatic resection: Back to where we started?
Ann Surg Oncol. 16:630–639. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Barlow WE and Prentice RL: Residuals for
relative risk regression. Biometrika. 75:65–74. 1988. View Article : Google Scholar
|
|
22
|
Fisher LD and Lin DY: Time-dependent
covariates in the Cox proportional-hazards regression model. Annu
Rev Public Health. 20:145–157. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Noh JH, Bae HJ, Eun JW, Shen Q, Park SJ,
Kim HS, Nam B, Shin WC, Lee EK, Lee K, et al: HDAC2 provides a
critical support to malignant progression of hepatocellular
carcinoma through feedback control of mTORC1 and AKT. Cancer Res.
74:1728–1738. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Quint K, Agaimy A, Di Fazio P, Montalbano
R, Steindorf C, Jung R, Hellerbrand C, Hartmann A, Sitter H,
Neureiter D, et al: Clinical significance of histone deacetylases
1, 2, 3, and 7: HDAC2 is an independent predictor of survival in
HCC. Virchows Arch. 459:129–139. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Song J, Noh JH, Lee JH, Eun JW, Ahn YM,
Kim SY, Lee SH, Park WS, Yoo NJ, Lee JY, et al: Increased
expression of histone deacetylase 2 is found in human gastric
cancer. APMIS. 113:264–268. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rikimaru T, Taketomi A, Yamashita Y,
Shirabe K, Hamatsu T, Shimada M and Maehara Y: Clinical
significance of histone deacetylase 1 expression in patients with
hepatocellular carcinoma. Oncology. 72:69–74. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chang HH, Chiang CP, Hung HC, Lin CY, Deng
YT and Kuo MY: Histone deacetylase 2 expression predicts poorer
prognosis in oral cancer patients. Oral Oncol. 45:610–614. 2009.
View Article : Google Scholar
|
|
28
|
Weichert W, Röske A, Gekeler V, Beckers T,
Ebert MP, Pross M, Dietel M, Denkert C and Röcken C: Association of
patterns of class I histone deacetylase expression with patient
prognosis in gastric cancer: A retrospective analysis. Lancet
Oncol. 9:139–148. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Koh WP, Robien K, Wang R, Govindarajan S,
Yuan JM and Yu MC: Smoking as an independent risk factor for
hepatocellular carcinoma: The Singapore Chinese Health Study. Br J
Cancer. 105:1430–1435. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kang H, Gillespie TW, Goodman M, Brodie
SA, Brandes M, Ribeiro M, Ramalingam SS, Shin DM, Khuri FR and
Brandes JC: Long-term use of valproic acid in US veterans is
associated with a reduced risk of smoking-related cases of head and
neck cancer. Cancer. 120:1394–1400. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yamaguchi T, Cubizolles F, Zhang Y,
Reichert N, Kohler H, Seiser C and Matthias P: Histone deacetylases
1 and 2 act in concert to promote the G1-to-S progression. Genes
Dev. 24:455–469. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Noh JH, Jung KH, Kim JK, Eun JW, Bae HJ,
Xie HJ, Chang YG, Kim MG, Park WS, Lee JY, et al: Aberrant
regulation of HDAC2 mediates proliferation of hepatocellular
carcinoma cells by deregulating expression of G1/S cell cycle
proteins. PLoS One. 6:e281032011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Aghdassi A, Sendler M, Guenther A, Mayerle
J, Behn CO, Heidecke CD, Friess H, Büchler M, Evert M, Lerch MM, et
al: Recruitment of histone deacetylases HDAC1 and HDAC2 by the
transcriptional repressor ZEB1 downregulates E-cadherin expression
in pancreatic cancer. Gut. 61:439–448. 2012. View Article : Google Scholar
|
